Rigour in diagnostic confirmation of CF in patients with RF mutations is important and a robust diagnostic protocol to ensure the accurate identification of CF in all patients analysed should be utilised, including comprehensive genetic testing to identify mutations in the CFTR gene and additional functional assays, such as nasal potential difference and intestinal current measurements, to corroborate the diagnosis. The gene discussed is CFTR; the disease is cystic fibrosis.